Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Integrated Biopharma Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Integrated Biopharma Inc since year 2005.
Table 2 shows the detailed insider transactions of Integrated Biopharma Inc since 2005.
The reporting company's ticker symbol is INB. The reporting company's CIK number is 1016504.
The total value of stock buying since 2005 is $78,368.
The total value of stock sales since 2005 is $22,500.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2012-06-27||Kay E Gerald (CEO AND PRESIDENT)||Sale||250,000||.09||22,500|
|2009-04-06||Desantis Carl (Director)||Buy||87,111||.53||46,168|
|2005-03-22||Kay E Gerald (Chairman and CEO)||Buy||5,000||6.44||32,200|
Insider trading activities including stock purchases, stock sales, and option exercises of INB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Integrated Biopharma Inc (symbol INB, CIK number 1016504) see the Securities and Exchange Commission (SEC) website.